Navigation Links
Mission Pharmacal Launches CitraNatal(R) Assure Prescription Prenatal Vitamin
Date:12/8/2008

Designed to ensure comfort and optimize nutrition for women and their babies

SAN ANTONIO, Dec. 8 /PRNewswire/ -- Mission Pharmacal today announced the addition of CitraNatal(R) Assure to its CitraNatal(R) family of prescription prenatal vitamins. CitraNatal Assure builds on the benefits of the CitraNatal line and offers increased nutrients for women and their babies.

Prenatal vitamins are an important resource for women who are pregnant or planning to become pregnant. They provide women with the essential vitamins and minerals they may be lacking from a healthy diet alone.

"CitraNatal Assure provides women with all the prenatal essentials of the CitraNatal line, and also offers increased levels of several vitamins and minerals," said Neill Walsdorf, Jr., President of Mission Pharmacal. "Mission Pharmacal is proud to add this unique formulation to the CitraNatal family to offer women another prenatal option to meet their individual needs."

CitraNatal Assure contains 300mg of Martek's life'sDHA(TM), a patented, plant-based form of the omega-3 fatty acid DHA, which is consistent with current published guidelines for pregnant and lactating women(1). DHA is the recommended essential fatty acid for prenatal care. It has been shown to be instrumental in the baby's pre- and postnatal brain, eye and nervous system development, increase the baby's gestation period, birth weight and size, lead to higher visual acuity at age 60 days, and increase cognitive and psychomotor developments(2,3,4). DHA cannot be produced naturally by the body; it must be gathered from diet or supplements.

CitraNatal Assure also offers increased levels of iron and vitamin B6. Vitamin B6 contributes to a baby's developing brain and nervous system(5) and may help some women reduce severe nausea or vomiting during pregnancy(6). It also helps the body maintain blood glucose levels, metabolize proteins, formulate neurotransmitters for normal nerve cell communication and makes hemoglobin to carry oxygen to tissues(7).

Pregnant women may experience improved comfort with CitraNatal Assure. CitraNatal Assure contains calcium citrate, a source known for proven absorption and no gas production to help ease GI discomfort during pregnancy, a gentle dual-iron formulation of carbonyl iron and ferrous gluconate for gentle absorption, tolerability and safety, and a stool softener to help ease constipation often associated with pregnancy.

The CitraNatal family of products offers four unique formulations of essential vitamins and minerals designed to ensure comfort and optimize nutrition for women and their babies. Women who are pregnant or planning to conceive should consult with their healthcare provider prior to beginning any prenatal vitamin regimen.

Aboutthe CitraNatal(R) Line

CitraNatal is marketed by Mission Pharmacal Company based in San Antonio, Texas. CitraNatal vitamins are specially formulated for the many women who require nutritional support prior to conception, throughout pregnancy, and during the postnatal period. The plant-derived DHA found in several CitraNatal products is produced exclusively by Martek Biosciences Corporation based in Columbia, Maryland.

About Mission Pharmacal

Mission Pharmacal is a privately held pharmaceutical company based in San Antonio, Texas. For more than 60 years, the company has been committed to meeting the unique needs of women throughout all stages of life, identifying unmet health needs in the marketplace, and developing innovative prescription and over-the-counter products to meet them. Currently, Mission Pharmacal provides physicians and consumers with pharmaceutical and nutritional products. For more information, visit www.missionpharmacal.com or www.citranatal.com.

(1) Simopoulos, A.P., et al. Workshop on the Essentiality of and Recommended Dietary Intakes for omega-6 and omega-3 Fatty Acids. Journal of the American College of Nutrition, 1999; 18 (5): 487-489.

(2) Smuts C.M., et al. A Randomized Trial of Docosahexaenoic Acid Supplementation During the Third Trimester of Pregnancy. American College of Obstetrics and Gynecology. 2003;101(3):469-479.

(3) Innis S.M., Friesen R.W. Essential n-3 Fatty Acids in Pregnant Women and Early Visual Acuity Maturation in Term Infants. American Journal of Clinical Nutrition. 2008;87: 548-557.

(4) Jacobson J.L., et al. Beneficial Effects of a Polyunsaturated Fatty Acid on Infant Development: Evidence from the Inuit of Arctic Quebec. The Journal of Pediatrics. 2008;152: 356-364.

(5) Mahomed K., Gulmezoglu A.M. Pyridoxine (vitamin B6) supplementation in pregnancy (Cochrane Review). In: The Cochrane Library, Issue 2, 2003. Accessed at: http://drug.pharmacy.psu.ac.th/wbfile/97254611283.doc. Last accessed November 24, 2008.

(6) Sahakian V., et al. Vitamin B6 Is Effective Therapy for Nausea and Vomiting of Pregnancy: A Randomized, Double Blind Placebo-Controlled Study. Obstetrics & Gynecology, 1991; 78(1): 33-36.

(7) Dietary Supplement Fact Sheet: Vitamin B6. Office of Dietary Supplements. National Institutes of Health. Accessed at: http://ods.od.nih.gov/factsheets/vitaminb6.asp. Last accessed November 24, 2008.


'/>"/>
SOURCE Mission Pharmacal Company
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Zevalin Consolidation in Patients With Complete Remission After Induction Therapy Results in Durable Remission of More Than 67 Months
2. Alfacell Provides ONCONASE(R) NDA Submission Update
3. Zevalin(R) Following Short-Course Chemotherapy with CHOP + Rituximab (CHOP-R) Doubles Complete Remission Rate in First-Line Treatment of Follicular Non- Hodgkins Lymphoma
4. Joint Commission Urges Patients to Speak Up About Pain
5. Quigley Anti-Viral Compound QR448(a) Successfully Prevents Transmission of Infectious Bronchitis in Chickens
6. n-3 PUFAs Reduce Mortality and Hospital Admissions in Patients With Symptomatic Heart Failure
7. Oregon Tourism Commission Unveils New Online Customer Service Training Program
8. FDA Reviewing Biomoda Submission for Cancer Screening Study
9. FluoroPharma Announces Positive Phase I Safety Results for BFPET(TM), Myocardial Perfusion Imaging (MPI) Tracer for Positron Emission Tomography (PET)
10. Eight-Year Melanoma Remission is Among Early Cancer Treatment Results
11. Patients Own Infection-Fighting T Cells Put Late-Stage Melanoma Into Long-Term Remission - Without Chemotherapy or Radiation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2016)... 2016 Research and Markets has ... by Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), ... Parenteral) - Global Forecast to 2021" report to ... The global pharmaceutical excipients market is projected to reach ... 6.1% in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... , June 23, 2016 ... CAPR ), a biotechnology company focused on ... today announced that patient enrollment in its ongoing ... Duchenne) has exceeded 50% of its 24-patient target. ... in the third quarter of 2016, and to ...
(Date:6/23/2016)... INDIANAPOLIS , June 23, 2016 ... Tomorrow,s Leaders Scholarship is any indication, the future is ... online at www.diabetesscholars.org by the Diabetes Scholars ... in the way of academic and community service excellence. ... program since 2012, and continues to advocate for people ...
Breaking Medicine Technology:
(Date:6/26/2016)... ... June 26, 2016 , ... Pixel Film Studios Released ... , "Film editors can give their videos a whole new perspective by using the ... CEO of Pixel Film Studios. , ProSlice Levels contains over 30 Different presets ...
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... ... The temporary closing of Bruton Memorial Library on June 21 due to a possible lice ... overlooked aspect of head lice: the parasite’s ability to live away from a human host, ... a necessary one in the event that lice have simply gotten out of control. , ...
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. ... his M.D from the David Geffen School of Medicine at UCLA. He trained in ... to complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he ...
(Date:6/25/2016)... ... 2016 , ... Conventional wisdom preaches the benefits of moderation, whether it’s a ... the bar too high can result in disappointment, perhaps even self-loathing. However, those who ... , Research from PsychTests.com reveals that behind the tendency to set ...
Breaking Medicine News(10 mins):